MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
about
Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.Radiotherapy planning using MRI.Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?Imaging of local recurrence in prostate cancer.Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials.Implementation of diffusion-weighted magnetic resonance imaging in target delineation of central lung cancer accompanied with atelectasis in precision radiotherapyFive-year follow-up using a prostate stent as fiducial in image-guided radiotherapy of prostate cancer.Treatment plan comparison between Tri-Co-60 magnetic-resonance image-guided radiation therapy and volumetric modulated arc therapy for prostate cancer.Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer.Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities.
P2860
Q31119375-A428C4B0-6ED8-4435-BDF1-73432BA0C74CQ31149479-549169DC-FB15-49DE-95A1-A8664D2FFF70Q35131928-9B440BDC-B656-423D-BA05-0424AE78C7F1Q35676729-F77CBF01-8F8B-42C1-A81B-F06EDEBB47D3Q37474137-41DC77C1-F542-4539-B4DB-82C22AA0F4BAQ37578562-679A7499-C0FB-497D-A4D3-75DD70F37D0AQ38852724-A4722294-0213-452C-8D65-99B7265B3D33Q40927190-8D339B07-5235-436E-ACCF-BF466928431AQ40965160-C4073776-D6F1-4AD7-9E81-A1391FA0776EQ41614749-7747F12A-3BBB-4CD3-A3E0-9225D0B5A1FDQ41651524-0F0DF699-3C8C-443B-9EC7-343EF3F3C884Q47111747-FA59A22D-42EF-4C95-8D6F-7FF90C8C8287Q51336618-E22D5BD6-2722-46BF-90AB-58C30D1F492AQ52997243-13879151-34B3-4E38-9CCB-9F394265A8BD
P2860
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@en
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@nl
type
label
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@en
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@nl
prefLabel
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@en
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@nl
P2093
P2860
P1433
P1476
MRI target delineation may reduce long-term toxicity after prostate radiotherapy.
@en
P2093
Jesper Carl
Lotte Sander
Mats Holmberg
Niels Christian Langkilde
P2860
P304
P356
10.3109/0284186X.2013.865077
P577
2013-12-20T00:00:00Z